Genmab | Ativo Circulante



Current Assets Alterar Data
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
Almirall EUR 714.05M 50.55M 2025-06
Amarin USD 573.06M 22.34M 2025-03
Amgen USD 26.73B 195M 2025-06
argenx SE 5.83B 946.64M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Bayer EUR 33.75B 1.08B 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Demant DKK 10.2B 282M 2025-06
Exelixis USD 1.18B 215.74M 2025-07
Fresenius Medical Care EUR 8.14B 178.09M 2025-06
Galapagos EUR 3.26B 217.04M 2025-06
Genmab DKK 3.91B 127M 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
GN Store Nord DKK 8.99B 105M 2025-06
GRIFOLS EUR 5.25B 393.8M 2025-06
Hikma Pharmaceutical USD 2.26B 22M 2024-12
Insmed USD 2.08B 678.89M 2025-06
Lonza CHF 5.44B 113M 2024-12
Merck EUR 12.2B 216M 2025-06
Novartis USD 25.94B 831M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 37.02B 7B 2025-06
UCB EUR 4.79B 1.47B 2024-12


Genmab Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.